Cargando…
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor
Autores principales: | Crees, Zachary D., Rettig, Michael P., Bashey, Asad, Devine, Steven M., Jaglowski, Samantha, Wan, Fei, Zhou, Amy, Harding, Melinda, Vainstein-Haras, Abi, Sorani, Ella, Gliko-Kabir, Irit, Grossman, Brenda J., Westervelt, Peter, DiPersio, John F., Uy, Geoffrey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500469/ https://www.ncbi.nlm.nih.gov/pubmed/37327120 http://dx.doi.org/10.1182/bloodadvances.2023010407 |
Ejemplares similares
-
Innovations in hematopoietic stem-cell mobilization: a review of the
novel CXCR4 inhibitor motixafortide
por: Crees, Zachary D., et al.
Publicado: (2023) -
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
por: Crees, Zachary D., et al.
Publicado: (2023) -
Targeting CXCR4 in AML and ALL
por: Cancilla, Daniel, et al.
Publicado: (2020) -
Structural Basis of the Binding Mode of the Antineoplastic Compound Motixafortide (BL-8040) in the CXCR4 Chemokine Receptor
por: Rebolledo-Bustillo, Mariana, et al.
Publicado: (2023) -
Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
por: Xiang, Jingyu, et al.
Publicado: (2022)